DOCK3
Dedicator of cytokinesis protein 3
Also known as: DOCK3_HUMAN, KIAA0299, MOCA, PBP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZD9
- Gene
- DOCK3
- Ensembl
- ENSG00000088538
- Chromosome
- 3
- Canonical length
- 2030 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene is specifically expressed in the central nervous system (CNS). It encodes a member of the DOCK (dedicator of cytokinesis) family of guanine nucleotide exchange factors (GEFs). This protein, dedicator of cytokinesis 3 (DOCK3), is also known as modifier of cell adhesion (MOCA) and presenilin-binding protein (PBP). The DOCK3 and DOCK1, -2 and -4 share several conserved amino acids in their DHR-2 (DOCK homology region 2) domains that are required for GEF activity, and bind directly to WAVE proteins [Wiskott-Aldrich syndrome protein (WASP) family Verprolin-homologous proteins] via their DHR-1 domains. The DOCK3 induces axonal outgrowth in CNS by stimulating membrane recruitment of the WAVE complex and activating the small G protein Rac1. This gene is associated with an attention deficit hyperactivity disorder-like phenotype by a complex chromosomal rearrangement. [provided by RefSeq, Aug 2010]
Canonical amino-acid sequenceUniProt
2030 residues, UniProt reviewed canonical sequence.
>Q8IZD9|DOCK3
1 MWTPTEEEKY GVVICSFRGS VPQGLVLEIG ETVQILEKCE GWYRGVSTKK PNVKGIFPAN
61 YIHLKKAIVS NRGQYETVVP LEDSIVTEVT ATLQEWASLW KQLYVKHKVD LFYKLRHVMN
121 ELIDLRRQLL SGHLTQDQVR EVKRHITVRL DWGNEHLGLD LVPRKDFEVV DSDQISVSDL
181 YKMHLSSRQS VQQSTSQVDT MRPRHGETCR MPVPHHFFLS LKSFTYNTIG EDTDVFFSLY
241 DMREGKQISE RFLVRLNKNG GPRNPEKIER MCALFTDLSS KDMKRDLYIV AHVIRIGRML
301 LNDSKKGPPH LHYRRPYGCA VLSILDVLQS LTEVKEEKDF VLKVYTCNNE SEWSQIHENI
361 IRKSSAKYSA PSASHGLIIS LQLLRGDMEQ IRRENPMIFN RGLAITRKLG FPDVIMPGDI
421 RNDLYLTLEK GDFERGGKSV QKNIEVTMYV LYADGEILKD CISLGSGEPN RSSYHSFVLY
481 HSNSPRWGEI IKLPIPIDRF RGSHLRFEFR HCSTKDKGEK KLFGFAFSTL MRDDGTTLSD
541 DIHELYVYKC DENSTFNNHA LYLGLPCCKE DYNGCPNIPS SLIFQRSTKE SFFISTQLSS
601 TKLTQNVDLL ALLKWKAFPD RIMDVLGRLR HVSGEEIVKF LQDILDTLFV ILDDNTEKYG
661 LLVFQSLVFI INLLRDIKYF HFRPVMDTYI QKHFAGALAY KELIRCLKWY MDCSAELIRQ
721 DHIQEAMRAL EYLFKFIVQS RILYSRATCG MEEEQFRSSI QELFQSIRFV LSLDSRNSET
781 LLFTQAALLN SFPTIFDELL QMFTVQEVAE FVRGTLGSMP STVHIGQSMD VVKLQSIART
841 VDSRLFSFSE SRRILLPVVL HHIHLHLRQQ KELLICSGIL GSIFSIVKTS SLEADVMEEV
901 EMMVESLLDV LLQTLLTIMS KSHAQEAVRG QRCPQCTAEI TGEYVSCLLS LLRQMCDTHF
961 QHLLDNFQSK DELKEFLLKI FCVFRNLMKM SVFPRDWMVM RLLTSNIIVT TVQYLSSALH
1021 KNFTETDFDF KVWNSYFSLA VLFINQPSLQ LEIITSAKRK KILDKYGDMR VMMAYELFSM
1081 WQNLGEHKIH FIPGMIGPFL GVTLVPQPEV RNIMIPIFHD MMDWEQRKNG NFKQVEAELI
1141 DKLDSMVSEG KGDESYRELF SLLTQLFGPY PSLLEKVEQE TWRETGISFV TSVTRLMERL
1201 LDYRDCMKGE ETENKKIGCT VNLMNFYKSE INKEEMYIRY IHKLCDMHLQ AENYTEAAFT
1261 LLLYCELLQW EDRPLREFLH YPSQTEWQRK EGLCRKIIHY FNKGKSWEFG IPLCRELACQ
1321 YESLYDYQSL SWIRKMEASY YDNIMEQQRL EPEFFRVGFY GRKFPFFLRN KEYVCRGHDY
1381 ERLEAFQQRM LSEFPQAVAM QHPNHPDDAI LQCDAQYLQI YAVTPIPDYV DVLQMDRVPD
1441 RVKSFYRVNN VRKFRYDRPF HKGPKDKENE FKSLWIERTT LTLTHSLPGI SRWFEVERRE
1501 LVEVSPLENA IQVVENKNQE LRSLISQYQH KQVHGNINLL SMCLNGVIDA AVNGGIARYQ
1561 EAFFDKDYIN KHPGDAEKIT QLKELMQEQV HVLGVGLAVH EKFVHPEMRP LHKKLIDQFQ
1621 MMRASLYHEF PGLDKLSPAC SGTSTPRGNV LASHSPMSPE SIKMTHRHSP MNLMGTGRHS
1681 SSSLSSHASS EAGNMVMLGD GSMGDAPEDL YHHMQLAYPN PRYQGSVTNV SVLSSSQASP
1741 SSSSLSSTHS APSQMITSAP SSARGSPSLP DKYRHAREMM LLLPTYRDRP SSAMYPAAIL
1801 ENGQPPNFQR ALFQQVVGAC KPCSDPNLSV AEKGHYSLHF DAFHHPLGDT PPALPARTLR
1861 KSPLHPIPAS PTSPQSGLDG SNSTLSGSAS SGVSSLSESN FGHSSEAPPR TDTMDSMPSQ
1921 AWNADEDLEP PYLPVHYSLS ESAVLDSIKA QPCRSHSAPG CVIPQDPMDP PALPPKPYHP
1981 RLPALEHDEG VLLREETERP RGLHRKAPLP PGSAKEEQAR MAWEHGRGEQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DOCK3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 19 nTPM
- cerebellum: 17 nTPM
- retina: 9.3 nTPM
- thyroid gland: 9 nTPM
- basal ganglia: 6.9 nTPM
- spinal cord: 6.2 nTPM
Single-cell type
- retinal horizontal cells: 1,140 nCPM
- oligodendrocytes: 964 nCPM
- brain inhibitory neurons: 959 nCPM
- brain excitatory neurons: 889 nCPM
- other brain neurons: 766 nCPM
- retinal amacrine cells: 739 nCPM
Immune cell
- non-classical monocyte: 0.3 nTPM
- naive CD4 T-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebral cortex: 84 nTPM
- white matter: 83 nTPM
- basal ganglia: 71 nTPM
- hippocampal formation: 59 nTPM
- amygdala: 51 nTPM
- pons: 50 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DOCK3.
Disease | AllUniProt
Conditions DOCK3 is implicated in, by any mechanism.
- Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia (NEDIDHA) MIM:618292
Disease | GeneticClinVar
13 pathogenic / likely-pathogenic of 340 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia
- DOCK3-related disorder
- Inborn genetic diseases
- Hypotonia
- Global developmental delay
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.16
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.94
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- neurotrophin TRK receptor signaling pathway
- regulation of small GTPase mediated signal transduction
- small GTPase-mediated signal transduction
Molecular functions
- GTPase activator activity
- guanyl-nucleotide exchange factor activity
- SH3 domain binding
- small GTPase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SH3 domain
- Armadillo-type fold
- Dedicator of cytokinesis
- C2 DOCK-type domain
- DOCKER domain
- Dedicator of cytokinesis, N-terminal domain
- C2 domain superfamily
- SH3-like domain superfamily
- Dedicator of cytokinesis B, C2 domain
- Dedicator of cytokinesis, N-terminal, subdomain 1
- Dedicator of cytokinesis, C-terminal, lobe A
- Dedicator of cytokinesis, C-terminal, lobe C
- DOCKER, Lobe A
- DOCKER, Lobe B
- DOCKER, Lobe C
- Dedicator of cytokinesis, TPR repeats region
- DHR-2, Lobe A
- Variant SH3 domain
- C2 domain in Dock180 and Zizimin proteins
- DOCK N-terminus
- DHR-2, Lobe C
- DHR-2, Lobe B
- Dedicator of cytokinesis (DOCK) TPR region
- Dedicator of cytokinesis protein 3, DHR2 domain
- Dedicator of cytokinesis 3, SH3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DOCK3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DOCK3 as an antibody target. Whether an autoantibody or antibody against DOCK3 could matter depends on whether native DOCK3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DOCK3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DOCK3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...